Literature DB >> 20731704

Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.

Wei Sun1, Shuang Yang, Wenwen Shen, Huihui Li, Yang Gao, Tian-Hui Zhu.   

Abstract

The lmo2 gene is a specific oncogene in T-cell leukemia, for its ectopic expression causes both increased pro-T-cell proliferation and differentiation arrest, leading to the onset of leukemia. Notably, DeltaEF1 (also known as ZEB1), a member of zinc finger-homeodomain family transcription factor, also exhibits crucial function in promoting T-cell differentiation. In this study, we found that DeltaEF1 was positively regulated by T-lineage-specific transcriptional regulator GATA3, while ectopically expressed LMO2 targeted to DeltaEF1 promoter by interaction with GATA3 and inhibited DeltaEF1 expression in transcriptional level. Moreover, LMO2 interacted with the N-terminal zinc finger domain of DeltaEF1 protein and inhibited its positive transcriptional regulatory function by this interaction. Taken together, our findings revealed that ectopically expressed LMO2 impaired the function of DeltaEF1 in both transcriptional and protein levels and identified DeltaEF1 as a novel pathogenic target of LMO2 in T-cell leukemia.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731704     DOI: 10.1111/j.1600-0609.2010.01519.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

Review 1.  Evolutionary functional analysis and molecular regulation of the ZEB transcription factors.

Authors:  Alexander Gheldof; Paco Hulpiau; Frans van Roy; Bram De Craene; Geert Berx
Journal:  Cell Mol Life Sci       Date:  2012-02-21       Impact factor: 9.261

2.  LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.

Authors:  Ye Liu; Di Huang; Zhaoyang Wang; Chao Wu; Zhao Zhang; Dan Wang; Zongjin Li; Tianhui Zhu; Shuang Yang; Wei Sun
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

3.  LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.

Authors:  Ye Liu; Zhaoyang Wang; Di Huang; Chao Wu; Huihui Li; Xin Zhang; Bin Meng; Zongjin Li; Tianhui Zhu; Shuang Yang; Wei Sun
Journal:  Oncotarget       Date:  2017-02-07

4.  LMO2 Enhances Lamellipodia/Filopodia Formation in Basal-Type Breast Cancer Cells by Mediating ARP3-Profilin1 Interaction.

Authors:  Ye Liu; Chao Wu; Tianhui Zhu; Wei Sun
Journal:  Med Sci Monit       Date:  2017-02-07

Review 5.  ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?

Authors:  Bieke Soen; Niels Vandamme; Geert Berx; Jürg Schwaller; Pieter Van Vlierberghe; Steven Goossens
Journal:  Hemasphere       Date:  2018-05-11

6.  Biochemical Feature of LMO2 Interactome and LMO2 Function Prospect.

Authors:  Wenhao Wang; Yaxin Chen; Ying Chang; Wei Sun
Journal:  Med Sci Monit Basic Res       Date:  2020-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.